Here you will find the Publications from 2010 onwards that were produced at IfADo.
Immunohistochemistry-based prognostic biomarkers in NSCLC: novel findings on the road to clinical use? Expert Rev Mol Diagn 15: 471-490 (2015)
Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells. J Hepatol 63: 934-942 (2015)
Gelsolin is associated with longer metastasis-free survival and reduced cell migration in estrogen receptor-positive breast cancer. Anticancer Res 35: 5277-5285 (2015)
The human endometrium-specific proteome defined by transcriptomics and antibody-based profiling. OMICS 19: 659-668 (2015)
Identification of sample annotation errors in gene expression datasets. Arch Toxicol 89: 2265-2272 (2015)
An integrative analysis of the tumorigenic role of TAZ in human non-small cell lung cancer. Clin Cancer Res 20: 4660-4672 (2014)
Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics 13: 397-406 (2014)
The lung-specific proteome defined by integration of transcriptomics and antibody-based profiling. FASEB J 28: 5184-5196 (2014)
The human liver-specific proteome defined by transcriptomics and antibody-based profiling. FASEB J 28: 2901-2914 (2014)
Prognostic impact of COX-2 in non-small cell lung cancer: a comprehensive compartment-specific evaluation of tumor and stromal cell expression. Cancer Lett 356: 837-845 (2014)
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer. Int J Cancer 135: 2206-2214 (2014)
Defining the human adipose tissue proteome to reveal metabolic alterations in obesity. J Proteome Res 13: 5106-5119 (2014)
Prognostic influence of pre-operative C-reactive protein in node-negative breast cancer patients. PLoS One 9(10): e111306 (2014) (9 pp)